Zepzelca 4 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FJK3V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,768
Award facts
- Contract value 100% obligated
- $20,768.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $20,768.08 to Amerisourcebergen Drug Corp for ZEPZELCA 4 MG vials on January 27, 2026, with an ultimate completion date of February 18, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation. The award was issued under Amerisourcebergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2031. This comprehensive IDC vehicle enables Cencora to supply pharmaceutical products and medical supplies globally to support military healthcare programs, veterans' health systems, and other federal medical institutions.
Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The company's work under the DLA contract encompasses a diverse range of pharmaceutical commodities including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The delivery order for ZEPZELCA, an oncology medication, reflects the company's role in supplying essential cancer treatment products to military treatment facilities and federal healthcare systems. This award demonstrates Amerisourcebergen's continued capability to fulfill competitive federal pharmaceutical procurement requirements through its parent organization's strategic partnership with the Defense Logistics Agency.
Quick answers
Who was awarded contract SPE2DR26FJK3V?
SPE2DR26FJK3V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26FJK3V worth?
The government has obligated $20,768 on SPE2DR26FJK3V.
Is contract SPE2DR26FJK3V an order under another contract?
Yes. SPE2DR26FJK3V is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJK3V competed?
The extent of competition for SPE2DR26FJK3V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award